Schweinstinger's Director of Operations for China, Rob Berry, is leaving

stephane Mascarau, managing director of French pharmaceutical giant Svea China, announced a personnel change to staff on Thursday, and Lloyd Bradley, now schweija's head of operations in China, was promoted to general manager of Schweija Australia, where he will leave China for Australia next month.With a senior resume of more than a decade at Schweinsteder, he has served as Sveya's National Sales Manager for Australia, National Sales Director for Canada, and Director of Medical Development in the United Kingdom.Prior to coming to the Chinese market, Mr. Roberli was the head of commercial operations at Schweijar poland and moved to China at the end of 2016 to be responsible for Schweijar's Operations in China.In a brief introduction, Svea is an international pharmaceutical company managed by a non-profit fund, headquartered in Surene, France, with international operations in 149 countries and approximately 22,000 employees worldwide.Schweija's continued pursuit of innovation in five areas of excellence: cardiovascular disease, immuno-inflammatory disease, neurodegenerative diseases, cancer and diabetes, is also driving Schweija's growth, and in addition to drug development, Schweija offers eHealth solutions.In 1979, Schweija became one of the first multinational companies to enter China, and the Chinese market has become the world's largest market for Schweija, with its business in 29 provinces and cities. (Medical representative)